Pacific Biosciences of California Dirección
Dirección controles de criterios 2/4
El CEO de Pacific Biosciences of California es Christian O. Henry , nombrado en Sep 2020, tiene una permanencia de 4.17 años. compensación anual total es $8.05M, compuesta por 8.6% salario y 91.4% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.14% de las acciones de la empresa, por valor de $860.82K. La antigüedad media del equipo directivo y de la junta directiva es de 4 años y 11.8 años, respectivamente.
Información clave
Christian O. Henry
Chief Executive Officer (CEO)
US$8.0m
Compensación total
| Porcentaje del salario del CEO | 8.6% |
| Permanencia del CEO | 4.2yrs |
| Participación del CEO | 0.1% |
| Permanencia media de la dirección | 4yrs |
| Promedio de permanencia en la Junta Directiva | 11.8yrs |
Actualizaciones recientes de la dirección
Recent updates
Pacific Biosciences' Cost Cuts Won't Offset Rising Competition
Nov 12Pacific Biosciences of California, Inc. (NASDAQ:PACB) Stock Rockets 56% But Many Are Still Ignoring The Company
Nov 07
Health Check: How Prudently Does Pacific Biosciences of California (NASDAQ:PACB) Use Debt?
Oct 16Even With A 37% Surge, Cautious Investors Are Not Rewarding Pacific Biosciences of California, Inc.'s (NASDAQ:PACB) Performance Completely
Sep 20Pacific Biosciences: A Speculative Play On Long-Read Genomics Sequencing
Aug 21Take Care Before Jumping Onto Pacific Biosciences of California, Inc. (NASDAQ:PACB) Even Though It's 33% Cheaper
Jul 02We Think Pacific Biosciences of California (NASDAQ:PACB) Has A Fair Chunk Of Debt
Jun 08Pacific Biosciences: Navigating Rough Waters In Gene Sequencing Seas
Jun 03These Analysts Think Pacific Biosciences of California, Inc.'s (NASDAQ:PACB) Sales Are Under Threat
Apr 25It's Down 25% But Pacific Biosciences of California, Inc. (NASDAQ:PACB) Could Be Riskier Than It Looks
Apr 16Pacific Biosciences' Pivot: From Shareholder Dilution To Expansion And Leadership
Mar 19Pacific Biosciences: Strong Cash And Doubling Revenue Signal Investment Growth
Feb 08With A 34% Price Drop For Pacific Biosciences of California, Inc. (NASDAQ:PACB) You'll Still Get What You Pay For
Feb 01What You Can Learn From Pacific Biosciences of California, Inc.'s (NASDAQ:PACB) P/S
Dec 18Does Pacific Biosciences of California (NASDAQ:PACB) Have A Healthy Balance Sheet?
Nov 13The Price Is Right For Pacific Biosciences of California, Inc. (NASDAQ:PACB) Even After Diving 27%
Aug 28Is Pacific Biosciences of California, Inc. (NASDAQ:PACB) Trading At A 32% Discount?
Jul 31Is It Time To Consider Buying Pacific Biosciences of California, Inc. (NASDAQ:PACB)?
Jul 06Pacific Biosciences of California (NASDAQ:PACB) Is Carrying A Fair Bit Of Debt
May 25Is Now The Time To Look At Buying Pacific Biosciences of California, Inc. (NASDAQ:PACB)?
Mar 29Is Pacific Biosciences of California, Inc. (NASDAQ:PACB) Worth US$8.8 Based On Its Intrinsic Value?
Feb 26Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$394m |
| Jun 30 2024 | n/a | n/a | -US$400m |
| Mar 31 2024 | n/a | n/a | -US$297m |
| Dec 31 2023 | US$8m | US$695k | -US$307m |
| Sep 30 2023 | n/a | n/a | -US$309m |
| Jun 30 2023 | n/a | n/a | -US$319m |
| Mar 31 2023 | n/a | n/a | -US$321m |
| Dec 31 2022 | US$7m | US$667k | -US$314m |
| Sep 30 2022 | n/a | n/a | -US$299m |
| Jun 30 2022 | n/a | n/a | -US$206m |
| Mar 31 2022 | n/a | n/a | -US$175m |
| Dec 31 2021 | US$3m | US$650k | -US$181m |
| Sep 30 2021 | n/a | n/a | -US$37m |
| Jun 30 2021 | n/a | n/a | -US$77m |
| Mar 31 2021 | n/a | n/a | -US$59m |
| Dec 31 2020 | US$13m | US$195k | US$29m |
| Sep 30 2020 | n/a | n/a | -US$46m |
| Jun 30 2020 | n/a | n/a | -US$51m |
| Mar 31 2020 | n/a | n/a | -US$53m |
| Dec 31 2019 | US$100k | n/a | -US$84m |
| Sep 30 2019 | n/a | n/a | -US$115m |
| Jun 30 2019 | n/a | n/a | -US$111m |
| Mar 31 2019 | n/a | n/a | -US$109m |
| Dec 31 2018 | US$88k | n/a | -US$103m |
Compensación vs. Mercado: La compensación total de Christian O.($USD8.05M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD3.18M).
Compensación vs. Ingresos: La compensación de Christian O. ha aumentado mientras la empresa no es rentable.
CEO
Christian O. Henry (56 yo)
4.2yrs
Permanencia
US$8,046,575
Compensación
Mr. Christian O. Henry, MBA, served as Independent Director at CM Life Sciences III Inc. since April 07, 2021 until December 2021. He has been President and Chief Executive Officer at Pacific Biosciences o...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 4.2yrs | US$8.05m | 0.14% $ 860.8k | |
| Chief Financial Officer | 4.2yrs | US$2.52m | 0.043% $ 262.0k | |
| Chief Operating Officer | 3.8yrs | US$4.60m | 0.12% $ 701.0k | |
| Chief Commercial Officer | 2.3yrs | US$2.53m | 0.050% $ 299.7k | |
| Co-Founder | 24.3yrs | US$466.76k | sin datos | |
| VP & Chief Accounting Officer | 3.5yrs | sin datos | 0.013% $ 80.3k | |
| General Counsel & Corporate Secretary | no data | sin datos | sin datos | |
| Chief People Officer | no data | sin datos | sin datos |
4.0yrs
Permanencia media
49.5yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de PACB se considera experimentado (4 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 6.3yrs | US$8.05m | 0.14% $ 860.8k | |
| Independent Director | 20.8yrs | US$259.00k | 0.0069% $ 41.7k | |
| Independent Director | 12.2yrs | US$255.00k | 0% $ 0 | |
| Independent Chairman | 11.3yrs | US$297.00k | 0.040% $ 243.7k | |
| Member of the Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of the Scientific Advisory Board | no data | sin datos | sin datos | |
| Independent Director | 15.8yrs | US$265.00k | 0% $ 0 | |
| Member of the Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of the Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of the Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of the Scientific Advisory Board | no data | sin datos | sin datos | |
| Chairman of Scientific Advisory Board | 2yrs | sin datos | sin datos |
11.8yrs
Permanencia media
70yo
Promedio de edad
Junta con experiencia: Los miembros de la junta directiva de PACB son experimentados ( 11.8 años antigüedad media).